2020 Infectious Disease Testing: US, Europe, Japan--A Rapidly Growing and Challenging Market--Supplier Shares and Segment Forecasts for 100 Tests--Technological Breakthroughs, Emerging Tests, Competitive Analysis

This new report is a seven-country strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key trends in the U.S., five major European countries (France, Germany, Italy, Japan, UK) and Japan; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests by assay, market segment, and country; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

/>Rationale

This comprehensive seven-country report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology testing market, in evaluating emerging opportunities and developing effective business strategies.

Microbiology testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade.  Among the main driving forces is continuing spread of AIDS, which remains the world’s major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs.

Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.

Worldwide Market Overview

- Estimated universe of laboratories performing
  infectious disease testing by country.

- Test volume and sales projections for major
  infectious disease diagnostic assays by country.

Opportunities and Strategic Recommendations

- Emerging opportunities for new instrumentation,
  reagents kits, IT and other products with significant market
  appeal during the next five years.

- Design criteria for decentralized testing products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter,
Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium,
Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea,
Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme disease,
Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps,
Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Geographic Coverage

- France
- Germany
- Italy
- Japan
- Spain
- UK
- US

Market Segmentation Analysis

- Sales and market shares of major suppliers
  by individual test and country.

- Volume and sales forecasts for over 100 infectious disease
   assays by country, individual test and market segment:

     ° Hospitals
     ° Blood Banks
     ° Commercial/Private Laboratories
     ° Physician Offices/Group Practices
     ° Public Health Laboratories

- Test volume estimates by method (molecular, serology/immunodiagnostics,
   culture/microscopy).

- Review of the market dynamics, trends, structure, size, growth
  and major suppliers by country.

Current and Emerging Products

- In-depth examination of over 100 major diseases,
  including their etiology, current diagnostic tests,
  vaccines, drugs and market needs.

- Review of major analyzers used for infectious disease
  testing, including their operating
  characteristics, features and selling prices.

Technology Review

- Assessment of molecular diagnostic, monoclonal antibody,
  immunoassay, and other technologies and their potential
  applications for infectious disease testing.

- Global listings of companies developing or
  marketing infectious disease diagnostic products
  by individual test.

Competitive Assessments

- Strategic assessments of major suppliers and
  emerging market entrants, including their sales, product
  portfolios, marketing tactics, collaborative
  arrangements and new products in R&D.


I. Introduction
II. Worldwide Market Overview
A. Business Environment
B. Market Structure
C. Market Size and Growth
III. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Information Technology
D. Auxiliary Products
IV. Design Criteria for Decentralized Testing Products
V. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
VI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VII. Worldwide Overview of Major Tests,
Technologies, and Instrumentation
A. Major Infectious Disease Tests
1. AIDS
2. Adenovirus
3. Aeromonas
4. Anthrax/Bacillus Anthracis
5. Arboviruses
6. Babesiosis
7. Bacillary Epithelioid Angiomatosis (BEA)
and Other Bartonella (Rochalimaea)
8. Blastocystis Hominis
9. Brucella
10. Campylobacter
11. Candida
12. Chagas Disease
13. Chancroid
14. Chlamydia
15. Clostridium Difficile
16. Coronaviruses
17. Coxsackieviruses
18. Creutzfeldt-Jakobs Disease
19. Cryptosporidium Parvum
20. Cyclospora Cayetanensis
21. Cytomegalovirus
22. Ebola Virus
23. E. Coli
24. EchoVirus
25. Encephalitis
26. Enteroviruses
27. Epstein-Barr Virus
28. Giardia Lamblia
29. Gonorrhea
30. Granuloma Inguinale
31. Hantavirus
32. Helicobacter Pylori

33. Hepatitis
34. Herpes Simplex Virus
35. Human Herpes Virus-6 (HHV-6)
36. Influenza Viruses
37. Legionella
38. Lyme Disease
39. Lymphogranuloma Venereum (LGV)
40. Malaria
41. Measles (Rubeola)
42. Meningitis
43. Microsporidium
44. Mononucleosis
45. Mumps
46. Mycoplasma
47. Papillomaviruses
48. Parvovirus B19
49. Pneumonia
50. Polyomaviruses
51. Pseudomonas Aeruginosa
52. Rabies
53. Respiratory Syncytial Virus (RSV)
54. RhinoViruses
55. RotaVirus (REOVIRUS)
56. Rubella(MEASLES)
57. Salmonellosis
58. Septicemia
59. Shigellosis
60. Staphylococcus Aureus
61. Streptococci
62. Syphilis
63. Toxoplasmosis
64. Trichomonas Vaginalis
65. Tuberculosis
66. Vibrio
67. West Nile Virus
68. Yersina

B. Instrumentation Review: Operating Characteristics,
Features and Selling Princes of Leading Automated
and Semiautomated Analyzers
C. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
D. Personal Testing
VIII. France
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth, Volume by Method, and Major Suppliers
Sales and Market Shares by Test
IX. Germany
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth, Volume by Method, and Major Suppliers
Sales and Market Shares by Test

X. Italy
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth Volume by Method, and Major Suppliers
Sales and Market Shares by Test
XI. Japan
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth, Volume by Method, and Major Suppliers
Sales and Market Shares by Test
XII. Spain
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth, Volume by Method, and Major Suppliers
Sales and Market Shares by Test
XIII. U.K.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth, Volume by Method, and Major Suppliers
Sales and Market Shares by Test
XIV. U.S.A.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth, Volume by Method, and Major Suppliers
Sales and Market Shares by Test

XV. Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- GSK Biologicals
- Hologic
- Leica Biosystems
- Lonza
- Ortho-Clinical Diagnostics
- PerkinElmer
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens Healthineers
- Takara Bio
- Thermo Fisher
- Wako
XVI. Appendix: Assumed Currency Exchange Rates

2020 Denmark Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: Supplier Shares and Strategies, Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities

This new report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities during the next five years, and assist industry executives in developing effective

USD 2450 View Report

2020 Czech Republic Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: Supplier Shares and Strategies, Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities

This new report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities during the next five years, and assist industry executives in developing effective

USD 2450 View Report

Global AI-Enabled Drug Discovery and Clinical Trials Market by Component (Solutions and Services), By Solution (Data Aggregation and Analysis, Clinical Trials, Drug Design, Drug Characterization, Biomarker Research and Others), By Therapeutic Applications (Oncology, Cardiovascular Diseases, Nervous System Diseases, Respiratory Disorder, Metabolic Diseases, Immunologic Diseases, Infectious Diseases and Others), By End-User(Biopharmaceutical Industry, Contract Research Organizations (CROs), and Academic Institutes and Research Centers), and By Region (North America, Europe, Asia Pacific, South America, and Middle East & Africa), Forecast to 2020 to 2027

Global AI-Enabled Drug Discovery and Clinical Trials Market by Component (Solutions and Services), By Solution (Data Aggregation and Analysis, Clinical Trials, Drug Design, Drug Characterization, Biomarker Research and Others), By Therapeutic Applications (Oncology, Cardiovascular Diseases, Nervous System Diseases, Respiratory Disorder, Metabolic Diseases, Immunologic Diseases, Infectious Diseases and Others), By End-User(Biopharmaceutical Industry, Contract Research Organizations (CROs), and Academic Institutes and Research Centers), and By Region (North America, Europe, Asia Pacific, South America, and Middle East & Africa), Forecast to 2020 to 2027 market research report available in single user pdf license with Aarkstore Enterprise at USD 4950

USD 4950 View Report

2020 Infectious Disease Testing Market: US, Europe, Japan--Supplier Shares, Country Forecasts, Supplier Profiles, Emerging Technologies, Instrumentation and Tests

This new 950-page report provides analysis of the global infectious disease testing market, including emerging tests, Technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers.The report presents:Estimated

USD 8500 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available